Lawrence Stanton
13Patents
3h-index
23Co-inventors
60Inventor score
Filing activity: Mar 17, 1999 → May 15, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6709855B1 | Methods for detection and use of differentially expressed genes in disease states | Chemistry; Metallurgy | 35 | Expired |
| US6322976A | Compositions and methods of disease diagnosis and therapy | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6800455B2 | Secreted factors | Human Necessities | 14 | Expired |
| US6342495B1 | Agonists and antagonists of peripheral-type benzodiazepine receptors | Chemistry; Metallurgy | 3 | Expired |
| US6686354B2 | Agonists and antagonists of peripheral-type benzodiazepine receptors | Chemistry; Metallurgy | 2 | Expired |
| US8460928B2 | Methods of specifying mesodermal, endodermal and mesoendodermal cell fates | Chemistry; Metallurgy | 2 | Active |
| US6380183B1 | Treatment of diseases involving cyst formation | Physics | 2 | Expired |
| US11806368B2 | Stem cell subpopulations with differential GSTT1 expression or genotype | Chemistry; Metallurgy | 0 | Active |
| US6936245B1 | Mediators of signal transduction | Chemistry; Metallurgy | 0 | Expired |
| US7202344B2 | Secreted factors | Human Necessities | 0 | Expired |
| US7482149B2 | Inhibition of SARS coronavirus infection with clinically approved antiviral drugs | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8907055B2 | Mutant sox proteins and methods of inducing pluripotency | Chemistry; Metallurgy | 0 | Active |
| US7153650B2 | Marker system for preparing and characterizing high-quality human embryonic stem cells | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.